Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Problems with ascribing between-trial differences in BCG effectiveness to sensitization with environmental mycobacteria.

Kernodle DS.

Clin Infect Dis. 2014 Aug 15;59(4):605-7. doi: 10.1093/cid/ciu329. Epub 2014 May 6. No abstract available.

PMID:
24803374
2.

A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.

Shoen CM, DeStefano MS, Hager CC, Tham KT, Braunstein M, Allen AD, Gates HO, Cynamon MH, Kernodle DS.

Vaccines (Basel). 2013 Jan 11;1(1):34-57. doi: 10.3390/vaccines1010034.

3.

SigH, antioxidants, and the pathogenesis of pulmonary tuberculosis.

Kernodle DS.

J Infect Dis. 2012 Apr 15;205(8):1186-8. doi: 10.1093/infdis/jis108. Epub 2012 Mar 7. No abstract available.

PMID:
22402036
4.

Warning: differences in the copy number of duplication unit 2 (DU2) within BCG Danish 1331 may influence findings involving genetically modified BCG Danish strains.

Kernodle DS.

Vaccine. 2012 Sep 14;30(42):6013-4; author reply 6015. doi: 10.1016/j.vaccine.2012.01.023. Epub 2012 Feb 10. No abstract available.

PMID:
22326901
5.

Mycobacterium tuberculosis RNA Expression Patterns in Sputum Bacteria Indicate Secreted Esx Factors Contributing to Growth are Highly Expressed in Active Disease.

Bukka A, Price CT, Kernodle DS, Graham JE.

Front Microbiol. 2012 Jan 10;2:266. doi: 10.3389/fmicb.2011.00266. eCollection 2011.

6.

Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.

Kernodle DS.

J Infect Dis. 2011 Jun 1;203(11):1692-3; author reply 1693-4. doi: 10.1093/infdis/jir141. No abstract available.

PMID:
21593000
8.

Re: Misleading comments in Ranganathan et al. "Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice".

Kernodle DS, Sadagopal S, Kalams SA.

Vaccine. 2010 Feb 25;28(9):2064-5. doi: 10.1016/j.vaccine.2009.12.029. Epub 2009 Dec 25. No abstract available.

PMID:
20038429
9.

Monitoring therapeutic efficacy by real-time detection of Mycobacterium tuberculosis mRNA in sputum.

Mdivani N, Li H, Akhalaia M, Gegia M, Goginashvili L, Kernodle DS, Khechinashvili G, Tang YW.

Clin Chem. 2009 Sep;55(9):1694-700. doi: 10.1373/clinchem.2009.124396. Epub 2009 Jul 2.

10.

Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG.

Sadagopal S, Braunstein M, Hager CC, Wei J, Daniel AK, Bochan MR, Crozier I, Smith NE, Gates HO, Barnett L, Van Kaer L, Price JO, Blackwell TS, Kalams SA, Kernodle DS.

PLoS One. 2009;4(5):e5531. doi: 10.1371/journal.pone.0005531. Epub 2009 May 13.

11.

Re: is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Kernodle DS.

J Infect Dis. 2007 Jun 1;195(11):1726; author reply 1727-8. No abstract available.

PMID:
17471445
12.

Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children.

Creech CB 2nd, Kernodle DS, Alsentzer A, Wilson C, Edwards KM.

Pediatr Infect Dis J. 2005 Jul;24(7):617-21.

PMID:
15999003
13.

Oral quinolones in hospitalized patients: an evaluation of a computerized decision support intervention.

Hulgan T, Rosenbloom ST, Hargrove F, Talbert DA, Arbogast PG, Bansal P, Miller RA, Kernodle DS.

J Intern Med. 2004 Oct;256(4):349-57.

14.

Benefits and harms of doxycycline treatment for Gulf War veterans' illnesses: a randomized, double-blind, placebo-controlled trial.

Donta ST, Engel CC Jr, Collins JF, Baseman JB, Dever LL, Taylor T, Boardman KD, Kazis LE, Martin SE, Horney RA, Wiseman AL, Kernodle DS, Smith RP, Baltch AL, Handanos C, Catto B, Montalvo L, Everson M, Blackburn W, Thakore M, Brown ST, Lutwick L, Norwood D, Bernstein J, Bacheller C, Ribner B, Church LW, Wilson KH, Guduru P, Cooper R, Lentino J, Hamill RJ, Gorin AB, Gordan V, Wagner D, Robinson C, DeJace P, Greenfield R, Beck L, Bittner M, Schumacher HR, Silverblatt F, Schmitt J, Wong E, Ryan MA, Figueroa J, Nice C, Feussner JR; VA Cooperative #475 Group.

Ann Intern Med. 2004 Jul 20;141(2):85-94.

PMID:
15262663
15.

p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia.

Sadikot RT, Zeng H, Yull FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM, Blackwell TS, Christman JW.

J Immunol. 2004 Feb 1;172(3):1801-8.

16.
17.

Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis.

Edwards KM, Cynamon MH, Voladri RK, Hager CC, DeStefano MS, Tham KT, Lakey DL, Bochan MR, Kernodle DS.

Am J Respir Crit Care Med. 2001 Dec 15;164(12):2213-9.

PMID:
11751190
18.

Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons.

Lakey DL, Voladri RK, Edwards KM, Hager C, Samten B, Wallis RS, Barnes PF, Kernodle DS.

Infect Immun. 2000 Jan;68(1):233-8.

19.
21.

Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

Voladri RK, Lakey DL, Hennigan SH, Menzies BE, Edwards KM, Kernodle DS.

Antimicrob Agents Chemother. 1998 Jun;42(6):1375-81.

22.

Beta-lactam drugs and tuberculosis.

Kernodle DS.

Clin Infect Dis. 1998 Apr;26(4):878-9. No abstract available.

PMID:
9564468
25.

Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections.

Kernodle DS, Classen DC, Stratton CW, Kaiser AB.

J Clin Microbiol. 1998 Jan;36(1):219-22.

26.
28.

Possible hazards of routine bacillus Calmette-Guérin immunization in human immunodeficiency virus-infected children.

Edwards KM, Kernodle DS.

Pediatr Infect Dis J. 1996 Sep;15(9):836-8. Review. No abstract available.

PMID:
8878234
29.

Nontropical pyomyositis in patients with AIDS.

Antony SJ, Kernodle DS.

J Natl Med Assoc. 1996 Sep;88(9):565-9. Review.

31.
32.

Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus.

Norris SR, Stratton CW, Kernodle DS.

Antimicrob Agents Chemother. 1994 Jul;38(7):1649-50.

35.
37.

Low-inoculum model of surgical wound infection.

Kaiser AB, Kernodle DS, Parker RA.

J Infect Dis. 1992 Aug;166(2):393-9.

PMID:
1634811
38.

Characterization of four beta-lactamases produced by Staphylococcus aureus.

Zygmunt DJ, Stratton CW, Kernodle DS.

Antimicrob Agents Chemother. 1992 Feb;36(2):440-5.

39.

Inappropriate dosing of cefuroxime in cardiac surgery.

Kaiser AB, Kernodle DS.

J Thorac Cardiovasc Surg. 1992 Jan;103(1):167-8. No abstract available.

PMID:
1728706
40.

Cefuroxime versus cefazolin as prophylaxis in vascular surgery.

Edwards WH Jr, Kaiser AB, Kernodle DS, Appleby TC, Edwards WH Sr, Martin RS 3rd, Mulherin JL Jr, Wood CA Jr.

J Vasc Surg. 1992 Jan;15(1):35-41; discussion 41-2.

PMID:
1728688
41.
42.

Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography.

Kernodle DS, Zygmunt DJ, McGraw PA, Chipley JR.

Antimicrob Agents Chemother. 1990 Nov;34(11):2177-83.

43.
44.

Vagal mononeuritis caused by herpes simplex virus: association with unilateral vocal cord paralysis.

Flowers RH 3rd, Kernodle DS.

Am J Med. 1990 Jun;88(6):686-8. No abstract available.

PMID:
2346163
45.

Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants.

Kernodle DS, McGraw PA, Stratton CW, Kaiser AB.

Antimicrob Agents Chemother. 1990 Mar;34(3):420-5.

46.

Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.

Kernodle DS, Classen DC, Burke JP, Kaiser AB.

JAMA. 1990 Feb 16;263(7):961-6.

PMID:
2299764
47.

Selecting cost-effective antimicrobial prophylaxis in surgery: are we getting what we pay for?

Roach AC, Kernodle DS, Kaiser AB.

DICP. 1990 Feb;24(2):183-5.

PMID:
2309513
48.
49.

Differentiation of beta-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles.

Kernodle DS, Stratton CW, McMurray LW, Chipley JR, McGraw PA.

J Infect Dis. 1989 Jan;159(1):103-8. No abstract available.

PMID:
2783329

Supplemental Content

Loading ...
Support Center